Showing results (1-10 of 85) with videos related to
Sort By:
Pageof 9
Clinical Medicine (London, England)|December 22, 2025
Metabolic dysfunction-associated steatotic liver diseaseCatherine Hsu, William AlazawiClinical Medicine (London, England)|September 16, 2020
Non-alcoholic fatty liver diseaseWenhao Li, William AlazawiFrontiers in Pharmacology|January 24, 2020
Genetics of Non-Alcoholic Fatty Liver and Cardiovascular Disease: Implications for Therapy?Karthik Chandrasekharan, William AlazawiCurrent Opinion in Infectious Diseases|August 30, 2008
Advances in the diagnosis and treatment of hepatitis BWilliam Alazawi, Graham R FosterThe Lancet. Gastroenterology & Hepatology|November 30, 2025
Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitisWenhao Li, William Alazawi, Rohit LoombaBriefings in Bioinformatics|November 6, 2023
Automated and reproducible cell identification in mass cytometry using neural networksHajar Saihi, Conrad Bessant, William AlazawiNature Medicine|March 11, 2020
Improving prevention strategies for cardiometabolic diseaseNaveed Sattar, Jason M R Gill, William AlazawiJHEP Reports : Innovation in Hepatology|November 29, 2023
National study of NAFLD management identifies variation in delivery of care in the UK between 2019 to 2022Wenhao Li, David Sheridan, Stuart McPherson, et al.Annals of Surgery|June 9, 2016
Inflammatory and Immune Responses to Surgery and Their Clinical ImpactWilliam Alazawi, Negar Pirmadjid, Rajiv Lahiri, et al.The Lancet Regional Health. Europe|January 6, 2026
Real-world evidence in metabolic dysfunction-associated steatotic liver disease (MASLD): insights, challenges, and future directionsHuei-Tyng Huang, Michael Hewitt, Wenhao Li, et al.Pageof 9